UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2656) 2656
Newsletter (76) 76
Book Chapter (53) 53
Newspaper Article (18) 18
Magazine Article (9) 9
Book / eBook (3) 3
Conference Proceeding (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2374) 2374
science & technology (1563) 1563
burkitt lymphoma - drug therapy (1554) 1554
life sciences & biomedicine (1499) 1499
male (1158) 1158
female (941) 941
burkitt lymphoma - pathology (776) 776
oncology (733) 733
biological and medical sciences (727) 727
child (724) 724
medical sciences (703) 703
burkitt's lymphoma (634) 634
adult (610) 610
antineoplastic combined chemotherapy protocols - therapeutic use (562) 562
adolescent (560) 560
hematology (527) 527
child, preschool (480) 480
lymphoma (412) 412
burkitt lymphoma (410) 410
cancer (376) 376
chemotherapy (371) 371
middle aged (361) 361
animals (360) 360
burkitt lymphoma - diagnosis (329) 329
hematologic and hematopoietic diseases (322) 322
abridged index medicus (315) 315
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (312) 312
burkitt lymphoma - genetics (301) 301
pharmacology. drug treatments (290) 290
treatment outcome (289) 289
cell line, tumor (288) 288
mice (288) 288
antineoplastic agents (274) 274
apoptosis (258) 258
burkitt lymphoma - metabolism (252) 252
burkitt lymphoma - complications (251) 251
burkitt lymphoma - immunology (239) 239
prognosis (238) 238
antineoplastic agents - therapeutic use (233) 233
cyclophosphamide - therapeutic use (229) 229
burkitt lymphoma - therapy (223) 223
cyclophosphamide - administration & dosage (219) 219
pediatrics (219) 219
tumors (219) 219
lymphomas (217) 217
methotrexate - administration & dosage (207) 207
research (193) 193
burkitt lymphoma - mortality (190) 190
aged (187) 187
vincristine - administration & dosage (187) 187
apoptosis - drug effects (184) 184
tumor cells, cultured (182) 182
hemic and lymphatic diseases (180) 180
infant (174) 174
care and treatment (166) 166
remission induction (164) 164
antineoplastic agents - pharmacology (162) 162
rituximab (159) 159
leukemia (155) 155
health aspects (147) 147
burkitt lymphoma - virology (143) 143
infectious diseases (141) 141
cytarabine - administration & dosage (140) 140
immunology (137) 137
doxorubicin - administration & dosage (134) 134
methotrexate - therapeutic use (130) 130
immunotherapy (129) 129
retrospective studies (129) 129
antineoplastic combined chemotherapy protocols - adverse effects (128) 128
drug therapy (128) 128
follow-up studies (128) 128
vincristine - therapeutic use (128) 128
antineoplastic combined chemotherapy protocols - administration & dosage (127) 127
neoplasm staging (123) 123
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (123) 123
time factors (122) 122
flow cytometry (121) 121
combined modality therapy (117) 117
non-hodgkin's lymphomas (117) 117
risk factors (117) 117
diagnosis, differential (116) 116
burkitt lymphoma - etiology (115) 115
dose-response relationship, drug (113) 113
epstein-barr virus (113) 113
children (111) 111
cell biology (109) 109
gene expression (104) 104
proteins (104) 104
biochemistry & molecular biology (103) 103
lymphoma, non-hodgkin - drug therapy (103) 103
burkitt lymphoma - epidemiology (102) 102
cell line (102) 102
prednisone - administration & dosage (102) 102
lymphocytes b (101) 101
disease-free survival (98) 98
recurrence (95) 95
lymphoma, large b-cell, diffuse - drug therapy (94) 94
pharmacology & pharmacy (94) 94
diagnosis (93) 93
survival rate (93) 93
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2604) 2604
French (65) 65
German (51) 51
Spanish (37) 37
Japanese (34) 34
Chinese (30) 30
Russian (21) 21
Italian (6) 6
Polish (6) 6
Danish (3) 3
Hungarian (3) 3
Dutch (2) 2
Norwegian (2) 2
Portuguese (2) 2
Bulgarian (1) 1
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical cancer research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4212 - 4223
Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Agammaglobulinaemia Tyrosine Kinase | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Mutation | Tumors | Cancer | B-cell lymphoma | Index Medicus | patient-derived xenograft | personalized therapy
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9822, pp. 1234 - 1244
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | General aspects | Infectious diseases | Viral diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Transcriptional Activation - genetics | Prognosis | HIV Infections - epidemiology | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Child, Preschool | Infant | Burkitt Lymphoma - epidemiology | Incidence | Endemic Diseases | Malaria - epidemiology | Burkitt Lymphoma - genetics | Epstein-Barr Virus Infections - genetics | Child | Burkitt Lymphoma - drug therapy | Epstein-Barr Virus Infections - epidemiology | Poverty - statistics & numerical data | Health Services Accessibility - statistics & numerical data | Burkitt Lymphoma - virology | Cross-Sectional Studies | Epstein-Barr Virus Infections - virology | Risk Factors | Rituximab | Epstein-Barr Virus Infections - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Proto-Oncogene Proteins c-myc - genetics | Translocation, Genetic - genetics | Care and treatment | Immunocompromised host | Patient outcomes | Genetic aspects | Risk factors | Burkitt's lymphoma | Diseases | Causes of | Practice guidelines (Medicine) | Diagnosis | Low income groups | Chemotherapy | Consolidation | Malaria | Human immunodeficiency virus--HIV | Cyclin-dependent kinases | Drug therapy | Epidemiology | Cancer therapies | Cancer | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Nature immunology, ISSN 1529-2908, 08/2017, Volume 18, Issue 8, pp. 889 - 898
Life Sciences & Biomedicine | Immunology | Science & Technology | Surface Plasmon Resonance | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Immunoglobulin Fc Fragments - metabolism | Complement C1q - immunology | Humans | Crystallography, X-Ray | Complement C1q - metabolism | Receptors, IgG - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Tandem Mass Spectrometry | Immunoglobulin Fc Fragments - immunology | Burkitt Lymphoma - immunology | Immunoglobulin G - immunology | Immunotherapy | Mass Spectrometry | Lymphoma, B-Cell - immunology | Chromatography, Liquid | Lymphoma, Large B-Cell, Diffuse - immunology | Burkitt Lymphoma - drug therapy | Lymphoma, B-Cell - drug therapy | Lymphoma, Large B-Cell, Diffuse - drug therapy | Enzyme-Linked Immunosorbent Assay | Crystallization | Phagocytosis - immunology | Antibodies, Monoclonal | Receptors, IgG - immunology | Neoplasms - drug therapy | Animals | Neoplasms - immunology | Cell Line, Tumor | Mice | Chromatography, Gel | Cytotoxicity, Immunologic - immunology | In Vitro Techniques | Immunoglobulin G - metabolism | Index Medicus | Lymphoma, Large B-Cell, Diffuse | Immunoglobulin G | Lymphoma, B-Cell | Neoplasms | Life Sciences | Immunoglobulin Fc Fragments | Burkitt Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Complement C1q | Receptors, IgG | Phagocytosis | Cytotoxicity, Immunologic | X-ray crystallography | Complement cascade | Cellular immunity | BASIC BIOLOGICAL SCIENCES | Cancer therapy
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 01/2014, Volume 32, Issue 1, pp. 44 - 50
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 327 - 340
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Hematologic and hematopoietic diseases | Infectious diseases | Investigative techniques, diagnostic techniques (general aspects) | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Viral diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Index Medicus | high-grade B-cell lymphoma | diffuse large B-cell lymphoma | cytogenetics
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 20, pp. 1915 - 1925
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | General aspects | Infectious diseases | Viral diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | HIV Seropositivity - complications | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Burkitt Lymphoma - complications | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - administration & dosage | Adolescent | Vincristine - adverse effects | Aged | Immunocompromised Host | Doxorubicin - adverse effects | Pediatrics | Laboratories | Leukemia | Nervous system | Cancer therapies | Doxorubicin | Fluids | Human immunodeficiency virus--HIV | Children | Drug dosages | Neurological disorders | Neutropenia | Cyclin-dependent kinases | Neutrophils | Etoposide | Rituximab | Prednisone | Vincristine | Patients | Lymphoma | Fever | Burkitt's lymphoma | Studies | Cyclophosphamide | Chemotherapy | Lymphocytes B | Lysis | B-cell lymphoma | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article